Close Menu
Home » Ambry

Ambry

Mar 08, 2016

Putting It Out There

Ambry Genetics is to make aggregated customer data publicly available, the New York Times says.

Apr 02, 2015

Ambry Genetics Acquires Progeny Software

Ambry will use Progeny's software solutions and risk assessment tools to simplify client workflows.

Jan 27, 2015

Utah Court Dismisses Two More BRCA Testing Patent Lawsuits against Labcorp, Ambry

A few more lawsuits related to Myriad Genetics' hereditary cancer testing patents are now put to bed. 

Jan 07, 2015

Ambry Expands Offerings with Launch of New Cardiovascular Genetic Testing Panels

Premium

The panels diagnose genetic heart disorders and are the first step in an expansion of the number of tests the firm intends to offer. 

Dec 17, 2014

Federal Appeals Court Upholds BRCA1/2 Decision Against Myriad Genetics

The court today upheld a federal district court's decision to deny a motion for a preliminary injunction by Myriad and other plaintiffs against Ambry Genetics.

Sep 24, 2014

Ambry, Academic Groups Partner to Create Hereditary Cancer Registry

NEW YORK (GenomeWeb) – Ambry Genetics and its collaborators today announced a partnership to create a hereditary cancer research registry leveraging next-generation sequencing.

Jun 25, 2014

Ambry, Kapa Bio Reach Deal on Exome Sequencing Assays

NEW YORK (GenomeWeb) – Ambry Genetics has chosen Kapa Biosystems' Kapa Hyper Prep Kits for Ambry's ExomeNext and ExomeNext-Rapid exome sequencing assays, the companies said this week.

Jun 25, 2014

Columbia Geneticists Find Routine Exome Sequencing Successful but Still Not First-line Choice

Premium

NEW YORK (GenomeWeb) — After more than three years offering clinical whole exome sequencing for pediatric and adult patients suspected of having rare genetic disorders, clinicians from Columbia University Medical Center have concluded that the approach is a feasible, useful, and timely option for

Jun 02, 2014

Multiple Institutions, Labs Collaborating on Registry to Study Rare Hereditary Cancer Genes

NEW YORK (GenomeWeb) – Memorial Sloan Kettering along with other academic research institutions and testing labs said they will launch a registry to collect the genomic and outcomes data of patients who have consented to prospective follow up after being tested with a multi-gene hereditary cancer

Mar 12, 2014

Denying Injunction against Ambry BRCA Testing, Utah Judge Unconvinced of Myriad's Legal Success

Premium

A US federal district court in Utah denied Myriad Genetics and other plaintiffs a preliminary junction that would have stopped Ambry Genetics from selling competing BRCA tests, even though the court determined this may harm Myriad's business.

Pages

The Scan

Possible Effect of Border DNA Testing

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

Commission to Develop Report on Germline Editing

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

To Boost Productivity

The US Department of Agriculture presents a new blueprint for animal genomic research.

This Week in Genome Research

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.